LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.
IPO Year: 2021
Exchange: NASDAQ
Website: lifestance.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/3/2024 | $7.00 | Underweight | Barclays |
| 5/15/2023 | $8.00 → $9.00 | Outperform → Market Perform | TD Cowen |
| 1/6/2023 | $8.00 | Equal-Weight → Overweight | Morgan Stanley |
| 11/7/2022 | $7.25 | Buy | Jefferies |
| 3/17/2022 | $19.00 → $10.00 | Buy → Neutral | UBS |
| 12/17/2021 | $15.00 → $10.00 | Equal-Weight | Morgan Stanley |
| 11/9/2021 | $24.00 → $12.00 | Overweight → Neutral | JP Morgan |
| 9/10/2021 | $18.00 | Outperform | Cowen & Co. |
| 8/16/2021 | $36.00 → $16.00 | Overweight → Equal-Weight | Morgan Stanley |
4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
3 - LifeStance Health Group, Inc. (0001845257) (Issuer)
4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
10-Q - LifeStance Health Group, Inc. (0001845257) (Filer)
10-Q - LifeStance Health Group, Inc. (0001845257) (Filer)
8-K - LifeStance Health Group, Inc. (0001845257) (Filer)
8-K - LifeStance Health Group, Inc. (0001845257) (Filer)
8-K - LifeStance Health Group, Inc. (0001845257) (Filer)
8-K - LifeStance Health Group, Inc. (0001845257) (Filer)
424B7 - LifeStance Health Group, Inc. (0001845257) (Filer)
424B7 - LifeStance Health Group, Inc. (0001845257) (Filer)
S-3ASR - LifeStance Health Group, Inc. (0001845257) (Filer)
10-Q - LifeStance Health Group, Inc. (0001845257) (Filer)
Barclays initiated coverage of LifeStance Health Group with a rating of Underweight and set a new price target of $7.00
TD Cowen downgraded LifeStance Health Group from Outperform to Market Perform and set a new price target of $9.00 from $8.00 previously
Morgan Stanley upgraded LifeStance Health Group from Equal-Weight to Overweight and set a new price target of $8.00
Jefferies resumed coverage of LifeStance Health Group with a rating of Buy and set a new price target of $7.25
UBS downgraded LifeStance Health Group from Buy to Neutral and set a new price target of $10.00 from $19.00 previously
Morgan Stanley reiterated coverage of LifeStance Health Group with a rating of Equal-Weight and set a new price target of $10.00 from $15.00 previously
JP Morgan downgraded LifeStance Health Group from Overweight to Neutral and set a new price target of $12.00 from $24.00 previously
Cowen & Co. initiated coverage of LifeStance Health Group with a rating of Outperform and set a new price target of $18.00
Morgan Stanley downgraded LifeStance Health Group from Overweight to Equal-Weight and set a new price target of $16.00 from $36.00 previously
SCOTTSDALE, Ariz., Oct. 17, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its third quarter 2024 earnings release before the market opens on Thursday, November 7, 2024. LifeStance will host a live earnings conference call to discuss third quarter results on November 7, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 2787723, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeS
SCOTTSDALE, Ariz., July 18, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its second quarter 2024 earnings release before the market opens on Thursday, August 8, 2024. LifeStance will host a live earnings conference call to discuss second quarter results on August 8, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 1488997, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance
SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2024 earnings release before the market opens on Thursday, May 9, 2024. LifeStance will host a live earnings conference call to discuss first quarter results on May 9, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 3005519, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Investor Re
SCOTTSDALE, Ariz., Feb. 07, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2023 earnings release before the market opens on Wednesday, February 28, 2024. LifeStance will host a live earnings conference call to discuss fourth quarter and full year results on February 28, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 7685503, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and P
SCOTTSDALE, Ariz., Oct. 18, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its third quarter earnings release before the market opens on Wednesday, November 8, 2023. LifeStance will host a live earnings conference call to discuss third quarter results on November 8, 2023, at 8:30 a.m. (Eastern time). To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 3827662, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Inve
SCOTTSDALE, Ariz., Aug. 09, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the second quarter ended June 30, 2023. (All results compared to prior-year comparative period, unless otherwise noted)Q2 2023 Highlights and FY 2023 Outlook Total revenue of $259.6 million increased $50.1 million or 24% compared to total revenue of $209.5 millionTotal clinicians of 6,132 up 17%, a sequential net increase of 171 in the second quarterNet loss of $45.5 million compared to net loss of $68.7 million, primarily driven by stock-based compensation expenseAdjusted EBITDA of $
SCOTTSDALE, Ariz., July 19, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its second quarter earnings release before the market opens on Wednesday, August 9, 2023. LifeStance will host a live earnings conference call to discuss second quarter results on August 9, 2023, at 8:30 a.m. (Eastern time). To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 7177364, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Invest
SCOTTSDALE, Ariz., May 10, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 2023. (All results compared to prior-year comparative period, unless otherwise noted)Q1 2023 Highlights and FY 2023 Outlook Total revenue of $252.6 million increased $49.5 million or 24% compared to revenue of $203.1 millionTotal clinicians of 5,961 up 19%, a sequential net increase of 330 in the first quarterNet loss of $34.2 million compared to net loss of $62.3 million, primarily driven by stock-based compensationAdjusted EBITDA of $10.1
SCOTTSDALE, Ariz., April 19, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter earnings release before the market opens on Wednesday, May 10, 2023. LifeStance will host a live earnings conference call to discuss first quarter results on May 10, 2023, at 8:30 a.m. (Eastern time). To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 1854301, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Investor Re
SCOTTSDALE, Ariz., Feb. 15, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter earnings release before the market opens on Wednesday, March 8, 2023. LifeStance will host a live earnings conference call to discuss fourth quarter results on March 8, 2023, at 8:30 a.m. (Eastern time). To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 4226236, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Investor
CHICAGO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Zarminali Health, the first outpatient pediatric destination purpose-built to provide modern, seamlessly coordinated primary and specialty care nationwide, today announced $40M in seed financing led by General Catalyst. The company will leverage the latest healthcare technology and an integrated approach to both primary and specialty care that alleviates family burdens and revitalizes patient and clinician experiences. This substantial funding, including a venture debt facility, will fuel the company's go-to-market vision and continue to support the opening of its initial locations in fall 2024 and beyond. Pediatric care today is long overdue f
SCOTTSDALE, Ariz., Oct. 17, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its third quarter 2024 earnings release before the market opens on Thursday, November 7, 2024. LifeStance will host a live earnings conference call to discuss third quarter results on November 7, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 2787723, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeS
Election stress is contributing to an increase in anxiety and strained relationships, reinforcing the importance of accessible mental healthcare SCOTTSDALE, Ariz., Oct. 8, 2024 /PRNewswire/ -- A LifeStance Health survey released today reveals how widespread election-related anxiety is impacting Americans' mental health, straining their personal relationships and prompting many to limit social media exposure. Nearly four out of five (79%) respondents said the upcoming U.S. presidential election has caused them anxiety this year. Key generational differences were evident, with
SCOTTSDALE, Ariz., Aug. 21, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 22nd Annual Morgan Stanley Global Healthcare Conference, which will be hosted in New York City, NY. Details of the presentation are as follows:Presenters: Dave Bourdon, CFODate: Wednesday, September 4, 2023 Time: 10:00 a.m. (Eastern time)Moderated by: Craig Hettenbach The presentation will be webcast live and will be available on the Events and Presentations section of the LifeStance Health Investor Relations website (https://investor.lifestance.com). A repl
Survey Also Reveals Differing Attitudes About Mental Health Content on Social Media, With TikTok Emerging as a Highly Used but Less Trusted Platform SCOTTSDALE, Ariz., Aug. 1, 2024 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today released findings from a new survey examining the state of Americans' mental health, their ability to access mental healthcare, how therapy ranks in their overall household budgets and the role that social media plays in shaping attitudes towards mental health. As the
SCOTTSDALE, Ariz., July 18, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its second quarter 2024 earnings release before the market opens on Thursday, August 8, 2024. LifeStance will host a live earnings conference call to discuss second quarter results on August 8, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 1488997, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance
SCOTTSDALE, Ariz., May 23, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will participate in the following upcoming investor conferences. UBS Healthcare Services Cape Cod SummitParticipants: Dave Bourdon, CFO, and Monica Prokocki, VP of Finance and Investor RelationsDate: Tuesday, June 4, 2024Location: Chatham Bars Inn, Chatham, MANote: No presentation due to event format; investor meetings only Goldman Sachs 45th Annual Healthcare ConferencePresenters: Dave Bourdon, CFO, and Monica Prokocki, VP of Finance and Investor RelationsDate: Monday, June 10, 2024Locatio
SCOTTSDALE, Ariz., May 21, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 20,000,000 shares of LifeStance's common stock, par value $0.01 per share (the "Common Stock") at a public offering price of $6.25 per share, pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the "SEC"). The underwriters will have a 30-day option to purchase up to an additional 3,000,000 shares of Common Stock from certain stockholders of the Company (th
SCOTTSDALE, Ariz., May 21, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that certain stockholders of the Company (the "Selling Stockholders") intend to offer 20,000,000 shares of LifeStance's common stock, par value $0.01 per share (the "Common Stock"), pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the "SEC"). The underwriters will have a 30-day option to purchase up to an additional 3,000,000 shares of common stock from the Selling Stockholders. The Selling Stockholders will re
SCOTTSDALE, Ariz., May 1, 2024 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today launched its 2024 "Not One Face" campaign designed to challenge assumptions about mental health and reduce the stigma around seeking treatment. The new campaign features photography from award-winning photographers and up-and-coming artists who shoot with Leica, known for its iconic, high-quality cameras. The photos showcase the diverse ways mental health conditions like depression and anxiety manifest in the real
SCOTTSDALE, Ariz., March 12, 2024 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today announced that Dr. Teresa DeLuca has joined the company's board of directors. Dr. DeLuca is a psychiatrist and accomplished physician executive with over 20 years of leadership experience, having held senior executive leadership roles at Magellan Health, Humana and Walgreens, and brings extensive healthcare operations and clinical management expertise to LifeStance's board of directors. "Dr. DeLuca's background
SCOTTSDALE, Ariz., Jan. 19, 2024 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today announced that Dr. Ujjwal Ramtekkar will join the company as Chief Medical Officer, effective January 22, 2024. He will lead all clinical services, ensuring that LifeStance's psychiatric and psychotherapy clinicians are enabled to deliver high-quality, personalized patient care that meets and exceeds professional standards. "Dr. Ramtekkar is an experienced physician executive with a demonstrated track record of d
SCOTTSDALE, Ariz., Nov. 3, 2022 /PRNewswire/ -- LifeStance Health (NASDAQ:LFST), one of the nation's largest providers of outpatient mental healthcare, today announced that effective November 10, 2022, J. Michael Bruff, currently Chief Financial Officer, will take on a new role as Business Transformation Officer. David Bourdon will join the company and succeed Bruff as Chief Financial Officer. Both executives will report directly to Ken Burdick, Chairman and Chief Executive Officer, LifeStance. During LifeStance's long-range planning process, the company's leadership team ide
Danish Qureshi Named President in Addition to Role as Chief Operating Officer SCOTTSDALE, Ariz., Sept. 8, 2022 /PRNewswire/ -- LifeStance Health (NASDAQ:LFST), one of the nation's largest providers of in-person and virtual outpatient mental healthcare, today announced that its Board of Directors has appointed Ken Burdick as the company's new Chief Executive Officer and Chairman, effective September 7. Burdick succeeds Michael Lester, who has served as the company's founding Chief Executive Officer and Chairman since 2017 and will be retiring. Lester will continue to serve as a Strategic Advisor to the company.
SCOTTSDALE, Ariz., July 7, 2022 /PRNewswire/ -- LifeStance Health Foundation (the "Foundation"), a 501(c)(3) non-profit organization endowed by LifeStance Health (NASDAQ:LFST), today announced the appointment of its first Executive Director, Gwen Booth, effective July 1, 2022. Booth will lead the Foundation's work to improve mental health access for especially vulnerable patients including youth and adolescents, underrepresented minority communities and the underemployed and uninsured. To date, the Foundation has awarded more than $400,000 to both national and local non-profit
Gwen Booth Retiring from COO Role; Appointed as Executive Director, LifeStance Health Foundation SCOTTSDALE, Ariz., May 23, 2022 /PRNewswire/ -- LifeStance Health (NASDAQ:LFST), one of the nation's largest providers of outpatient mental healthcare, today announced that its Board of Directors approved the appointment of Danish Qureshi, currently Chief Growth Officer, LifeStance, as the company's next Chief Operating Officer, effective July 1, 2022. Gwen Booth, who has served as COO since the company's founding in 2017, is retiring from her operating role and will become the first Executive Director of LifeStance Health Foundation (the "Foundation"). Established in 2021, the Foundation is a 50
SCOTTSDALE, Ariz., Aug. 24, 2021 /PRNewswire/ -- LifeStance Health (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced that Seema Verma, former administrator for the Centers for Medicare & Medicaid Services (CMS), has been elected to the company's Board of Directors. Verma is a leading national health policy expert with over two decades of experience in the healthcare industry. As the longest-serving CMS administrator in modern history, she oversaw health insurance programs for over 140 million Americans and set out to transf
SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)
SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)
SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)
SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)
SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)
SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)
SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)
SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)
SC 13G - LifeStance Health Group, Inc. (0001845257) (Subject)
SC 13G - LifeStance Health Group, Inc. (0001845257) (Subject)
LifeStance Health Gr's (NYSE:LFST) short percent of float has fallen 5.99% since its last report. The company recently reported that it has 16.01 million shares sold short, which is 20.1% of all regular shares that are available for trading. Based on its trading volume, it would take traders 9.96 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short
As the 19th Benzinga Cannabis Capital Conference, returns (Oct. 8-9) in Chicago, gathering top CEOs, investors, and leaders in the cannabis industry, let’s scroll through the latest leadership changes within the space. Get your tickets now before prices go up by following this link. Cannabis Board Updates Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors. Auxly Cannabis Group Inc. (TSX:XLY) (OTCQB:CBWTF) said on Tuesday that each of the directors listed as a nominee in the circular was elected as a director of the company, including: Genevieve Young; Hugo Alves; Troy Grant; Vikram Bawa; and Conrad Tat
Simply Solventless Concentrates Ltd. (TSXV:HASH) is acquiring Lifeist Wellness Inc.'s (TSXV:LFST) (FRANKFURT: M5B) (OTC:LFSWF) subsidiary CannMart Inc. What Happened The Calgary, Alberta-based company said on Wednesday that it has entered into a services agreement regarding the operations of CannMart and a share purchase agreement with Lifeist Wellness Inc. to acquire all of the shares of CannMart. See also: Canadian Company Lifeist Says Farewell To Cannabis Business Unit, Turns To Nutraceuticals Key terms of the services agreement are as follows: SCC will receive the benefit of 100% of CannMart’s revenue, less a service fee of 10% of net revenue; SSC will help to manage
Lifeist Finalizes Sale of Australian Vaporizers Lifeist Wellness Inc. (TSXV:LFST) (FRANKFURT: M5B) (OTC:LFSWF) said on Wednesday it has sold Australian Vaporizers Pty Ltd., its wholly owned Australian subsidiary to Flora Growth Corp. (NASDAQ:FLGC). The sale, first announced in September 2023, was wrapped up through a share purchase agreement, under which Lifeist has sold the issued and outstanding shares of Aussie Vapes to Flora, for roughly CA$900,000 ($658,439). The sum is payable by Flora issuing from treasury to Lifeist 550,000 of its common shares. Lifeist delivered CA$400,000 of inventory (as opposed to CA$1.1 million of inventory in the previous agreement) and CA$50,000 cash
LifeStance Health Group Inc (NASDAQ:LFST) shares are trading lower by 19.8% to $6.00 during Wednesday’s session after the company announced pricing of a 20 million share offering by selling stockholders. The company’s secondary public offering of 20 million shares of its common stock at $6.25 per share. The underwriters have a 30-day option to purchase an additional 3 million shares from certain stockholders. The selling stockholders will receive all the proceeds, as LifeStance itself is not selling any shares or receiving any proceeds from the offering. The offering is anticipated to close around May 24, pending customary closing conditions. See Also: Disgraced FTX Founder Sam Ban
Shares of XP Inc. (NASDAQ:XP) fell sharply during Wednesday's session after the company reported worse-than-expected first-quarter EPS results. XP posted quarterly earnings of 37 cents per share, missing market estimates of 40 cents per share. The company's quarterly sales came in at $818.79 million versus expectations of $784.08 million, according to data from Benzinga Pro. XP shares dipped 11.5% to $18.99 on Wednesday. Here are some other stocks moving in today’s mid-day session. Gainers Akoustis Technologies, Inc. (NASDAQ:AKTS) shares climbed 213.3% to $0.4254 after the company reportedly floated the probability of bankruptcy after losing a lawsuit against Qorvo. Barnes
Gainers IGM Biosciences (NASDAQ:IGMS) shares increased by 36.6% to $11.49 during Wednesday's regular session. The market value of their outstanding shares is at $678.1 million. Akso Health Group (NASDAQ:AHG) stock moved upwards by 21.96% to $1.05. The company's market cap stands at $153.8 million. MultiPlan (NYSE:MPLN) shares rose 18.57% to $0.64. The company's market cap stands at $415.4 million. Cyclerion Therapeutics (NASDAQ:CYCN) shares rose 14.61% to $2.98. The company's market cap stands at $7.4 million. TransCode Therapeutics (NASDAQ:RNAZ) shares increased by 12.79% to $1.41. The company's market cap stands at $9.3 million. Indaptus Therapeutics (NASDAQ:INDP) shares moved upward
Shares of Urban Outfitters, Inc. (NASDAQ:URBN) rose sharply in today's pre-market trading after the company reported better-than-expected financial results for its first quarter on Tuesday. The company reported quarterly earnings of 69 cents per share, which beat the analyst consensus estimate of 52 cents. Quarterly sales clocked in at $1.2 billion, beating the analyst consensus estimate of $1.175 billion, according to data from Benzinga Pro. Urban Outfitters shares jumped 6.7% to $44.10 in the pre-market trading session. Here are some other stocks moving in pre-market trading. Gainers MGO Global, Inc. (NASDAQ:MGOL) gained 91.2% to $2.39 in pre-market trading. MGO Global shar
Gainers Mustang Bio (NASDAQ:MBIO) stock increased by 51.6% to $0.47 during Wednesday's pre-market session. The market value of their outstanding shares is at $5.8 million. NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares increased by 30.78% to $5.99. The market value of their outstanding shares is at $29.3 million. Rezolute (NASDAQ:RZLT) shares rose 25.0% to $3.75. The company's market cap stands at $150.5 million. Akso Health Group (NASDAQ:AHG) stock moved upwards by 16.26% to $1.0. The market value of their outstanding shares is at $146.6 million. Coeptis Therapeutics (NASDAQ:COEP) shares increased by 15.72% to $0.39. The company's market cap stands at $14.4 million. Qilian Intl Hldg Gr